Skip to main content
Equibles

Wealthspire Advisors, LLC

Position in XWEL — XWELL, Inc.

CIK 1646247 NEW YORK, NY
Back to XWEL Full portfolio

Position in XWEL

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$109,306
New position
Shares Held
105,102
first reported quarter
Ownership
1.22%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 23 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority Sole 0% Shared 0% None 100%

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Wealthspire Advisors, LLC holds $14,238,925 across 10 Diagnostics & Research names. XWEL ranks #10 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 6,737 $3,377,662
2 IDXX
Idexx Laboratories Inc /De
 4,941 $2,601,140
3 DHR
Danaher Corp /De/
 12,506 $2,382,142
4 MTD
Mettler Toledo International Inc/
 1,565 $1,999,303
5 NTRA
Natera, Inc.
 5,786 $1,570,609
6 LH
Labcorp Holdings Inc.
 3,178 $889,840
7 GH
Guardant Health, Inc.
 3,636 $545,509
8 WAT
Waters Corp /De/
 1,020 $382,540

All Filings in XWEL

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-06-30 $109,306 105,102